After closely following the company's partnership
Post# of 72440
(Total Views: 243)
Posted On: 09/11/2017 1:15:38 PM
After closely following the company's partnership language over the past year, I was of the opinion it would be P first, which makes total sense, but then 2 things happened.
1) P enrollment took longer than expected.
2) OM enrollment increased significantally
Based on these 2 events, my bet is on B as well. B has been proven safe from the ABSSSI trials; B has been shown to be effective in the UP open label trial; finally, the placebo controlled OM will show it will hold up in double blind, placebo controlled trials
Either BP gives Leo a great deal for B, or he will wait a month or two and land a P deal...
1) P enrollment took longer than expected.
2) OM enrollment increased significantally
Based on these 2 events, my bet is on B as well. B has been proven safe from the ABSSSI trials; B has been shown to be effective in the UP open label trial; finally, the placebo controlled OM will show it will hold up in double blind, placebo controlled trials
Either BP gives Leo a great deal for B, or he will wait a month or two and land a P deal...
(4)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼